Vision and ophthalmology stocks
Heavily traded in Vision and ophthalmology
Turnover over $10M/day23 of about 50 companies in this theme turn over more than $10M in a typical session. Largest market value first. Data as of Sep 15, 2026.
| Company | Turnover | 1Y return | Next report |
|---|---|---|---|
| EL.PAEssilorLuxottica Société anonyme | $90.26M | −44.62% | — |
| 7741.THOYA Corporation | $22.32B | +5.13% | Oct 30, 2026 |
| COOThe Cooper Companies, Inc. | $103.09M | −17.20% | — |
| GKOSGlaukos Corporation | $118.20M | +112.17% | Oct 28, 2026 |
| BLTEBelite Bio, Inc | $27.43M | +158.98% | Nov 9, 2026 |
| TARSTarsus Pharmaceuticals, Inc. | $67.72M | +61.22% | Nov 4, 2026 |
| 4536.TSanten Pharmaceutical Co., Ltd. | $1.99B | +7.96% | Nov 5, 2026 |
| WRBYWarby Parker Inc. | $58.44M | −2.47% | Nov 5, 2026 |
Turnover is the median value traded in one session, measured over the past 50 sessions. It describes trading activity in a stock and nothing about the company behind it.
Table
51 companies, largest market value first.
Data as of Sep 15, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| EL.PA | EssilorLuxottica Société anonyme | $78.23B | Large cap | −44.62% |
| 7741.T | HOYA Corporation | $48.68B | Large cap | +5.13% |
| COO | The Cooper Companies, Inc. | $10.31B | Large cap | −17.20% |
| C1OO34.SA | The Cooper Companies, Inc. | $10.29B | Large cap | −20.46% |
| GKOS | Glaukos Corporation | $10.09B | Large cap | +112.17% |
| BLTE | Belite Bio, Inc | $6.97B | Mid cap | +158.98% |
| BLCO.TO | Bausch + Lomb Corporation | $6.26B | Mid cap | +16.05% |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.74B | Mid cap | +61.22% |
| FIE.DE | Fielmann Group AG | $3.68B | Mid cap | −28.82% |
| 4536.T | Santen Pharmaceutical Co., Ltd. | $3.62B | Mid cap | +7.96% |
| A2LC34.SA | Alcon Inc. | $3.57B | Mid cap | −7.42% |
| WRBY | Warby Parker Inc. | $3.18B | Mid cap | −2.47% |
| AFX.DE | Carl Zeiss Meditec AG | $3.06B | Mid cap | −28.12% |
| OCUL | Ocular Therapeutix, Inc. | $2.35B | Mid cap | −14.51% |
| BHC.TO | Bausch Health Companies Inc. | $2.22B | Mid cap | −16.58% |
| KOD | Kodiak Sciences Inc. | $2.08B | Mid cap | +254.44% |
| EYE | National Vision Holdings, Inc. | $1.38B | Small cap | −25.84% |
| STAA | STAAR Surgical Company | $1.16B | Small cap | −16.62% |
| SGP | SpyGlass Pharma, Inc. | $958.62M | Small cap | +8.56% |
| 3046.T | JINS HOLDINGS Inc. | $889.79M | Small cap | −41.17% |
| 7780.T | Menicon Co., Ltd. | $826.51M | Small cap | +47.39% |
| SFL.MI | Safilo Group S.p.A. | $786.27M | Small cap | +10.70% |
| OCS | Oculis Holding AG | $588.60M | Small cap | −38.85% |
| SGHT | Sight Sciences, Inc. | $447.87M | Small cap | +131.25% |
| KITS.TO | Kits Eyecare Ltd. | $377.73M | Small cap | −1.97% |
| EYPT | EyePoint, Inc. | $366.40M | Small cap | −68.31% |
| 5889.T | Japan Eyewear Holdings Co., Ltd. | $361.79M | Small cap | +0.83% |
| 262A.T | Intermestic Inc. | $344.13M | Small cap | −40.36% |
| RXST | RxSight, Inc. | $253.93M | Small cap | −33.86% |
| SRZN | Surrozen, Inc. | $209.68M | Small cap | +53.12% |
| 7743.T | SEED Co.,Ltd. | $156.10M | Small cap | +47.27% |
| OTLK | Outlook Therapeutics, Inc. | $155.30M | Small cap | −39.24% |
| LENZ | LENZ Therapeutics, Inc. | $140.45M | Small cap | −88.83% |
| LNSR | LENSAR, Inc. | $95.95M | Micro cap | −36.71% |
| ALDX | Aldeyra Therapeutics, Inc. | $88.08M | Micro cap | −71.32% |
| KLRS | Kalaris Therapeutics, Inc. | $78.56M | Micro cap | −11.05% |
| OKYO | OKYO Pharma Limited | $73.47M | Micro cap | −33.01% |
| 4596.T | Kubota Pharmaceutical Holdings Co., Ltd. | $68.64M | Micro cap | −10.81% |
| 4512.T | Wakamoto Pharmaceutical Co.,Ltd. | $67.04M | Micro cap | −0.35% |
| MRX.DE | Mister Spex SE | $44.56M | Micro cap | −34.99% |
| 4890.T | Tsubota Laboratory Incorporated | $43.82M | Micro cap | −24.86% |
| ALCOX.PA | Nicox S.A. | $37.60M | Micro cap | −4.71% |
| 9854.T | Aigan Co.,Ltd. | $35.60M | Micro cap | +42.71% |
| EYE.AX | Nova Eye Medical Limited | $28.61M | Micro cap | −11.86% |
| 4576.T | D. Western Therapeutics Institute, Inc. | $25.28M | Micro cap | −35.24% |
| 7782.T | Sincere Co., LTD. | $20.88M | Micro cap | −13.40% |
| KPRX | Kiora Pharmaceuticals, Inc. | $11.72M | Micro cap | +1.53% |
| IRIX | IRIDEX Corporation | $11.24M | Micro cap | −50.00% |
| 0GWJ.L | Clínica Baviera, S.A. | — | — | +28.96% |
| ALC.SW | Alcon Inc. | — | — | −11.54% |
| WIVN26.MI | Ivision Tech SpA | — | — | −97.33% |
Covers ~23,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Price and the 52-week distance are in the currency the stock trades in; only market values are converted.
We cover 51 companies grouped under the Vision and ophthalmology theme. The median market value in the group is $412.80M. Across the group, the median move over the past trading day is +0.38%. 33% of the 49 with a 200-day average trade above it. Price change over the past year runs from −44.6% to +53.1% across the middle 80 percent of the group, with a median of −11.9%.